Therefore, it is tempting to suggest that GRK2 might impact VEGF-C expression via pathways downstream of HuR phosphorylation to foster lymphangiogenesis and metastases of luminal breast cancer cells. The gene discussed is VEGFC; the disease is breast cancer.